Eculizumab for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplantation
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Eculizumab (Primary)
- Indications Delayed graft function
- Focus Therapeutic Use
- 11 Aug 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.
- 10 Jun 2017 Biomarkers information updated
- 22 Feb 2017 Status changed from recruiting to active, no longer recruiting.